Abstract
Purpose
The purpose of this study was to assess whether pre-operative 99mTc-methoxyisobutylisonitrile (MIBI) scintigraphy and neck ultrasound (US) are of value in improving the outcome of subtotal parathyroidectomy in patients with secondary hyperparathyroidism.
Methods
Forty-eight consecutive haemodialysis patients with severe secondary hyperparathyroidism prospectively underwent “blinded” subtotal parathyroid surgery, with 1-year follow-up to establish cure or relapse of their secondary hyperparathyroidism. Double-phase 99mTc-MIBI scintigraphy and neck US were performed pre-operatively in all patients. When the preserved gland showed 99mTc-MIBI uptake or an abnormal size on US, it was considered that “99mTc-MIBI advice” and “US advice”, respectively, had not been followed. Pre-operative and follow-up parathyroid hormone (PTH) levels were obtained in all patients. All data were evaluated on a patient by patient basis.
Results
Four parathyroid glands were identified in each patient at primary surgery, resulting in an operative success rate of 100%. Their weight ranged from 15 to 7,300 mg (mean 1,120±900 mg). Nine of the 48 patients (19%) showed a recurrence of their secondary hyperparathyroidism. The recurrence rate was 2% (1/48) and 10% (5/48), respectively, when 99mTc-MIBI and US advice was followed. The sensitivity, specificity, NPV and PPV for pre-operative imaging were 72%, 95%, 97% and 80% respectively for 99mTc-MIBI, and 55%, 67%, 87% and 28% for US.
Conclusion
99mTc-MIBI scintigraphy is a reliable non-invasive exploratory tool and its preoperative use results in a significant reduction in the number of recurrences in haemodialysis patients with secondary hyperparathyroidism who are candidates for subtotal parathyroidectomy. The use of neck US did not significantly improve the results obtained with 99mTc-MIBI alone.
Similar content being viewed by others
References
Andress DL. Intravenous versus oral vitamin D therapy in dialysis patients: what is the question? Am J Kidney Dis 2001;38:S41–4
Ishibashi M, Nishida H, Hiromatsu Y, Kojima K, Tabuchi E, Hayabuchi N. Comparison of technetium-99m-MIBI, technetium-99m-tetrofosmin, ultrasound and MRI for localization of abnormal parathyroid glands. J Nucl Med 1998;39:320–4
Rubello D, Mazzarotto R, Casara D. The role of technetium-99m methoxyisobutylisonitrile scintigraphy in the planning of therapy and follow-up of patients with differentiated thyroid carcinoma after surgery. Eur J Nucl Med 2000;27:331–40
Rubello D, Saladini G, Casara D, Borsato N, Toniato A, Piotto A, et al. Parathyroid imaging with pertechnetate plus perchlorate/MIBI subfraction scintigraphy–a fast and effective technique. Clin Nucl Med 2000;25:527–31
Casara D, Rubello D, Piotto A, Pelizzo MR. 99mTc-MIBI radio-guided minimally invasive parathyroid surgery planned on the basis of a preoperative combined 99mTc-pertechnetate/99mTc-MIBI and ultrasound imaging protocol. Eur J Nucl Med 2000;27:1300–4
Casara D, Rubello D, Cauzzo C, Pelizzo MR. Tc-99m-MIBI radio-guided minimally invasive parathyroidectomy: Experience with patients with normal thyroids and nodular goiters. Thyroid 2002;12:53–61
Geatti O, Shapiro B, Orsolon PG, Proto G, Guerra UP, Antonucci F, et al. Localization of parathyroid enlargement—experience with Tc-99m methoxyisobutylisonitrile and Tl-201 scintigraphy, ultrasonography and computed-tomography. Eur J Nucl Med 1994;21:17–22
Gofrit ON, Lebensart PD, Pikarsky A, Lackstein D, Gross DJ, Shiloni E. High-resolution ultrasonography: highly sensitive, specific technique for preoperative localization of parathyroid adenoma in the absence of multinodular thyroid disease. World J Surg 1997;21:287–91
Torregrosa JV, Fernandez-Cruz L, Canalejo A, Vidal S, Astudillo E, Almaden Y, et al. 99mTc-sestamibi scintigraphy and cell cycle in parathyroid glands of secondary hyperparathyroidism. World J Surg 2000;24:1386–90
Piga M, Bolasco P, Satta L, Altieri P, Loi G, Nicolosi A, et al. Double-phase parathyroid technetium-99m-MIBI scintigraphy to identify functional autonomy in secondary hyperparathyroidism. J Nucl Med 1996;37:565–9
Proye CA, Carnaille B, Bizard JP, Quievreux JL, Lecomte-Houcke M. Multiglandular disease in seemingly sporadic primary hyperparathyroidism revisited—where are we in the early 1990s—a plea against unilateral parathyroid exploration. Surgery 1992;112:1118–22
Pons F, Torregrosa JV, Vidal-Sicart S, Sabater L, Fuster D, Fernandez-Cruz L, et al. Preoperative parathyroid gland localization with technetium-99m sestamibi in secondary hyperparathyroidism. Eur J Nucl Med 1997;24:1494–8
Ishibashi M, Nishida H, Okuda S, Suekane S, Hayabuchi N. Localization of parathyroid glands in hemodialysis patients using Tc-99m sestamibi imaging. Nephron 1998;78:48–53
Olaizola I, Zingraff J, Heuguerot C, Fajardo L, Leger A, Lopez J, et al. [Tc-99m]-sestamibi parathyroid scintigraphy in chronic haemodialysis patients: static and dynamic explorations. Nephrol Dial Transpl 2000;15:1201–6
Spanu A, Falchi A, Manca A, Marongiu P, Cossu A, Pisu N, et al. The usefulness of neck pinhole SPECT as a complementary tool to planar scintigraphy in primary and secondary hyperparathyroidism. J Nucl Med 2004;45:40–8
Lorberboym M, Minski I, Macadziob S, Nikolov G, Schachter P. Incremental diagnostic value of preoperative Tc-99m-MIBI SPECT in patients with a parathyroid adenoma. J Nucl Med 2003;44:904–8
Price DC. Radioisotopic evaluation of the thyroid and the parathyroids. Radiol Clin North Am 1993;31:991–1015
Hindie E, Urena P, Jeanguillaume C, Melliere D, Berthelot JM, Menoyo-Calonge V, et al. Preoperative imaging of parathyroid glands with technetium-99m-labelled sestamibi and iodine-123 subtraction scanning in secondary hyperparathyroidism. Lancet 1999;353:2200–4
Giordano A, Rubello D, Casara D. New trends in parathyroid scintigraphy. Eur J Nucl Med 2001;28:1409–20
Sofferman RA, Nathan MH. The ectopic parathyroid adenoma: a cost justification for routine pre-operative localization with technetium-99m-sestamibi scan. Arch Otolaryngol Head Neck Surg 1998;124:649–54
Lumachi F, Ermani M, Basso S, Zucchetta P, Borsato N, Favia G. Localization of parathyroid tumours in the minimally invasive era: which technique should be chosen? Population-based analysis of 253 patients undergoing parathyroidectomy and factors affecting parathyroid gland detection. Endocr Relat Cancer 2001;8:63–9
Levin KE, Clark OH. The reasons for failure in parathyroid operations. Arch Surg 1989;124:911–5
Wang CA, Gaz RD, Moncure AC. Mediastinal parathyroid exploration—a clinical and pathological study of 47 cases. World J Surg 1986;10:687–95
Bruining HA, Birkenhager JC, Ong GL, Lamberts SWJ. Causes of failure in operations for hyperparathyroidism. Surgery 1987;101:562–5
Rothmun M, Wagner P. Reoperations for persistent and recurrent secondary hyperparathyroidism. Ann Surg 1988;207:310–4
Vallejos V, Martin-Comin J, Mora J, Gonzalez MT, Rafecas A, Munoz A, et al.Use of 99mTc-tetrofosmin scintigraphy in the diagnosis of patients with hyperparathyroidism. Rev Esp Med Nucl 1998;17:94–101
Ambrosoni P, Olaizola I, Heuguerot C, Parodi MN, Caorsi H, Caputti S, et al. The role of imaging techniques in the study of renal osteodystrophy. Am J Med Sci 2000;320:90–5
Olaizola I, Aznarez A, Jorgetti V, Petraglia A, Caorsi H, Acuna G, et al. Are there any differences in the parathyroid response in the different types of renal osteodystrophy? Nephrol Dial Transpl 1998;13 (Suppl 3):15–8
Torregrosa JV, Palomar MR, Pons F, Sabater L, Gilabert R, Llovera J, et al. Has double-phase MIBI scintigraphy usefulness in the diagnosis of hyperparathyroidism? Nephrol Dial Transpl 1998;13:37–40
Fuster D, Ybarra J, Torregrosa JV, Setoain X, Martin F, Ortega ML, et al. Double-phase parathyroid Tc-99m-sestamibi scintigraphy in chronic haemodialysis patients: correlation with biochemical markers of parathyroid function. Nucl Med Commun 2003;24:85–90
Torregrosa JV, Fuster D, Ybarra J, Moreno A, Valveny N. Predicting the effect of intravenous calcitriol on parathyroid gland activity using double-phase 99mTc-sestamibi scintigraphy. Am J Kidney Dis 2004;44:476–80
Neumann DR, Esselstyn CB Jr, Madera A, Wong CO, Lieber M. Parathyroid detection in secondary hyperparathyroidism with I-123/Tc-99m-sestamibi subtraction single photon emission computed tomography. J Clin Endocr Metab 1998;83:3867–71
Kao A, Shiau YC, Tsai SC, Wang JJ, Ho ST. Technetium-99m methoxyisobutylisonitrile imaging for parathyroid adenoma: relationship to P-glycoprotein or multidrug resistance-related protein expression. Eur J Nucl Med Mol Imagin 2002;29:1012–5
Krausz Y, Shiloni E, Bocher M, Agranovicz S, Manos B, Chisin R. Diagnostic dilemmas in parathyroid scintigraphy. Clin Nucl Med 2001;26:997–1001
Iwata M, Kasagi K, Misaki T, Matsumoto K, Iida Y, Ishimori T, et al. Comparison of whole-body 18F-FDG PET, 99mTc-MIBI SPET, and post-therapeutic 131I-Na scintigraphy in the detection of metastatic thyroid cancer. Eur J Nucl Med 2004;31:491–8
Acknowledgements
This research was supported in part by the grants RTICCC C03/10 and IM3 G03/185 from the Instituto de Salud Carlos III.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Fuster, D., Ybarra, J., Ortin, J. et al. Role of pre-operative imaging using 99mTc-MIBI and neck ultrasound in patients with secondary hyperparathyroidism who are candidates for subtotal parathyroidectomy. Eur J Nucl Med Mol Imaging 33, 467–473 (2006). https://doi.org/10.1007/s00259-005-0021-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00259-005-0021-2